NEU neuren pharmaceuticals limited

I know I am one of the people who speaks about shorting, often...

  1. 2,504 Posts.
    lightbulb Created with Sketch. 681
    I know I am one of the people who speaks about shorting, often but I agree with what you've written here. It may have some impact but it doesn't explain the 12-18 month disconnect from share price performance and the value creation the business has done in that time period so to blame shorting doesn't make sense and I agree with that.

    The thing that does seem odd is the amount of turnover (volume) generated. We're a 1.5b market cap company with reasonable shares on issue (125m~), but a single broker/group has generated 78m shares worth of volume of stock in just the last 12 months? Is that considered normal? if we look at the top 5 net sellers who are all US investment banks they've traded 176m shares between themselves and we only have 125m shares on issue. I know they are trading back and forth but they need a reasonable pool of shares to begin with surely?

    Maybe that's the case for everything in the indexes and it's just a constant back and forth of computer based trading and rebalancing activities.


    Last edited by htae39: Clarity 20/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$12.96
Change
-0.140(1.07%)
Mkt cap ! $1.613B
Open High Low Value Volume
$13.20 $13.36 $12.92 $1.917M 145.4K

Buyers (Bids)

No. Vol. Price($)
3 221 $12.94
 

Sellers (Offers)

Price($) Vol. No.
$12.96 76 5
View Market Depth
Last trade - 11.47am 16/06/2025 (20 minute delay) ?
NEU (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.